Lv51
1184 积分 2021-08-12 加入
Hallmarks of cancer—Then and now, and beyond
2小时前
已完结
Ruxolitinib for Ciltacabtagene Autoleucel-Associated Refractory Diarrhea
3小时前
已完结
On-target off-tumor toxicity of claudin18.2-directed CAR-T cells in preclinical models
3小时前
已关闭
Remodeling of T and endothelial cells during total neoadjuvant therapy in rectal cancer
2个月前
已完结
Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C
4个月前
已完结
Optimisation of locally advanced MSI-H/dMMR colorectal cancer treatment with neoadjuvant pembrolizumab using data-driven delay integro-differential equations
5个月前
已关闭
Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma
5个月前
已完结
Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer
6个月前
已完结
Humoral determinants of checkpoint immunotherapy
6个月前
已完结
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
6个月前
已完结
皖公网安备34019202002308
